Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate efficacy and safety of GemOx(Gemcitabine and
Oxaliplatin) combination with rituximab(R) as first-line treatment of elderly patients with
DLBCL
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University WEI XU